Complementary lipid-lowering therapies

被引:2
|
作者
McDermott, JH [1 ]
机构
[1] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
关键词
D O I
10.1093/ajhp/56.16.1668
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:1668 / 1671
页数:4
相关论文
共 50 条
  • [42] ADHERENCE, COMPLIANCE, AND PERSISTENCE WITH LIPID-LOWERING THERAPIES: A SYSTEMATIC REVIEW
    Xu, Y.
    Worden, C.
    VALUE IN HEALTH, 2016, 19 (03) : A50 - A50
  • [43] Lipid-lowering therapies and achievement of LDL-cholesterol targets
    Rizzo, Manfredi
    Banach, Maciej
    Montalto, Giuseppe
    Mikhailidis, Dimitri P.
    ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (04) : 598 - 600
  • [44] Overcoming toxicity and side-effects of lipid-lowering therapies
    Wilkinson, Michael J.
    Laffin, Luke J.
    Davidson, Michael H.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 28 (03) : 439 - 452
  • [45] Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures?
    Deshotels, Matthew R.
    Virani, Salim S.
    Ballantyne, Christie M.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (09)
  • [46] Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures?
    Matthew R. Deshotels
    Salim S. Virani
    Christie M. Ballantyne
    Current Cardiology Reports, 2021, 23
  • [47] Complementary, additive benefit of clopidogrel and lipid-lowering therapy in patients with atherosclerosis
    Bhatt, DL
    Foody, JAM
    Hirsch, AT
    Ringleb, P
    Hacke, W
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 326A - 326A
  • [48] Lipid-Lowering Drugs
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1506): : 133 - 140
  • [49] LIPID-LOWERING DRUGS
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1980, 22 (16): : 65 - 66
  • [50] Lipid-lowering drugs
    K. Pahan
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1165 - 1178